Skip to content
flowss
Start freeChecking your session
Business model canvas templates

Business Model Canvas — Continuous Glucose Monitor

Regulated glucose sensor sold through NHS commissioners rather than to patients, pricing a consumable against clinical, regulatory and quality-system costs, with the reimbursement case the whole model rests on still an assumption.

Business model canvasBusiness & StrategyBusiness model canvas syntax docs
Template previewBusiness model canvas
Lumen CGM — 14-day continuous glucose sensorBusiness model canvas✓23 validated?4 assumed0 unmarked8Key partners3✓✓Contract manufacturer inGalway✓Notified body for MDRconformity assessment✓Two university diabetescentres running the trials7Key activities3✓✓Sterile consumablemanufacture✓Post-market surveillanceand vigilance reporting✓Health-economic modellingfor each ICB business case6Key resources3✓✓CE-marked design under ISO13485✓Enzyme membrane patentrunning to 2039✓Pivotal trial dataset, 312participants2Value propositions2✓ 1?✓Fourteen days on onesensor, no fingerstickcalibration✓MARD of 8.4% in the pivotalstudy?Lower cost per patient-yearthan the incumbent4Customer relationships3✓✓Clinician dashboard fed byconsented patient data✓Nurse-led device helpline,24 hours✓Patient app with nosubscription attached3Channels2✓ 1?✓ICB formulary submissionsand tenders✓Diabetes specialist nurseeducation days?Community pharmacydispensing on FP101Customer segments2✓ 1?✓Type 1 adults on multipledaily injections✓NHS diabetes servicescommissioning at ICB level?Type 2 adults on insulin(expansion)9Cost structure£496.2k/mo✓Sensor COGS 6.80/sensor x 9k/mo✓Clinical and regulatory affairs 4.2m/yr✓QMS audit and notified body fees240k/yr✓Field clinical team 780k/yr5Revenue streams£314.1k/mo?Sensor supply to three ICBs34.50/sensor x 9k/mo✓Clinic data licences 2400/yr x 18Evidence85%Claims judged27 of 27Blocks filled9 of 9Empty blocksnoneCost / month£496.2kRevenue / month£314.1kMonthly delta-£182.1kBusiness model canvas — 27 notes across 9 of 9 blocks; 23 of 27 judged claims validated (85%).Monthly margin -58% on £314.1k of recognised revenue.

Make it your own.

title "Lumen CGM — 14-day continuous glucose sensor"
layout bmc
currency GBP

segments: "Type 1 adults on multiple daily injections" !, "NHS diabetes services commissioning at ICB level" !, "Type 2 adults on insulin (expansion)" ?
value: "Fourteen days on one sensor, no fingerstick calibration" !, "MARD of 8.4% in the pivotal study" !, "Lower cost per patient-year than the incumbent" ?
channels: "ICB formulary submissions and tenders" !, "Diabetes specialist nurse education days" !, "Community pharmacy dispensing on FP10" ?
relationships: "Clinician dashboard fed by consented patient data" !, "Nurse-led device helpline, 24 hours" !, "Patient app with no subscription attached" !
revenue: "Sensor supply to three ICBs 34.50/sensor x 9k/mo" ?, "Clinic data licences 2400/yr x 18" !

resources: "CE-marked design under ISO 13485" !, "Enzyme membrane patent running to 2039" !, "Pivotal trial dataset, 312 participants" !
activities: "Sterile consumable manufacture" !, "Post-market surveillance and vigilance reporting" !, "Health-economic modelling for each ICB business case" !
partners: "Contract manufacturer in Galway" !, "Notified body for MDR conformity assessment" !, "Two university diabetes centres running the trials" !
costs: "Sensor COGS 6.80/sensor x 9k/mo" !, "Clinical and regulatory affairs 4.2m/yr" !, "QMS audit and notified body fees 240k/yr" !, "Field clinical team 780k/yr" !